693 Effect of IL 3 on Transduction Efficiency in CD34+ Cell Derived Erythroid Cultures with Lentiviral Vectors Expressing the Human beta Flobin Gene Molecular Therapy Volume 17, Supplement 1, May 2009[.]
Trang 1Molecular Therapy Volume 17, Supplement 1, May 2009 Copyright © The American Society of Gene Therapy
S264
STEM CELL THERAPIES II
690 Antioxidant Treatment of Muscle Stem
Cells for Transplantation Increases Cardiac Repair
Lauren Drowley,1 Masaho Okada,1 Bradley Keller,2 Kimimasa
Tobita,2 Johnny Huard.1
1 University of Pittsburgh, Pittsburgh, PA; 2 Pediatrics, Children’s
Hospital of Pittsburgh, Pittsburgh, PA.
One major issue with cellular transplantation for cardiac repair has
been the poor survival of the transplanted cells, which is related to
the limited functional recovery seen clinically This is in part due to
the local environment at the site of transplantation, with oxidative
stress, infl ammation, and ischemia all playing key roles The ability
of cells to survive in this harsh environment could be critical in the
repair process, and cells that have increased survival could have a
greater impact on functional repair We have previously shown that
muscle-derived stem cells (MDSCs) signifi cantly ameliorate the
remodeling process in the ischemic heart compared to myoblasts
after myocardial infarction MDSCs also have lower levels of
apoptosis than myoblasts when oxidative stress is induced with
hydrogen peroxide Based on these results, we hypothesized that
one major characteristic of stem cells was an enhanced ability to
survive in stressful environments and that by up or down-regulating
antioxidants, we could infl uence repair To examine this, we reduced
levels of glutathione, a prevalent antioxidant, in MDSCs with diethyl
maleate (DEM), and also treated cells with N-acetylcysteine (NAC),
a molecule that has direct antioxidant effects as well as increasing
glutathione synthesis We examined in vitro characteristics including
cell survival after stress, proliferation, differentiation, and VEGF
secretion and found that antioxidant levels played a role in each In
a mouse model of myocardial infarction, we found that NAC-treated
MDSCs signifi cantly increased cardiac function, have decreased
formation of scar tissue, and increased levels of angiogenesis
compared to untreated and DEM-treated MDSCs These results show
that antioxidant treatment prior to cell transplantation can have a
signifi cant benefi cial effect
691 Sleeping Beauty-Mediated Gene Transfer
into Hematopoietic Stem Cells
Kendra A Hyland,1 Erik R Olson,1 Ron T McElmurry,2 Bruce R
Blazar,2 R Scott McIvor,1 Jakub Tolar.2
1 Discovery Genomics, Inc., Minneapolis, MN; 2 Pediatrics, Medical
School, University of Minnesota, Minneapolis, MN.
The Sleeping Beauty (SB) transposon system can transpose
sequences into mammalian chromosomes, supporting long term
expression of both reporter and therapeutic genes Advantages of the
SB system include ease of manufacture, the lack of genotoxic effects
after transposition and the absence of immunological complications
due to repeated administration Hematopoietic stem cells (HSC) are an
ideal target cell as they are used in therapy for a variety of hematologic
and other conditions Optimization of electroporation conditions,
assessed with a green fl uorescent protein (GFP) reporter plasmid and
a CytoPulse electroporator, included varying voltage, pulse width,
and pulse number to improve the loading of purifi ed cell populations
containing HSC, such as mouse lineage negative cells and human
umbilical cord blood CD34+ cells Cell viability was reduced by
10-30% compared to untreated cells, 1 to 2 days after electroporation
alone We demonstrate successful in vitro electroporation of
transposon and reporter plasmid DNA into mouse HSC, such that
5-10% of lineage negative cKit+ Sca-1+ cells (SKL) expressed GFP
on day 1 and 25-30% of human CD34+ cord blood cells expressed
GFP on day 2 post electroporation SB-mediated transposition of
HSC with a transposon containing the L22Y mutated dihydrofolate
reductase (DHFR) gene conferred methotrexate resistance after
electroporation as assessed in hematopoietic progenitor cells by in
vitro colony forming cell assays Studies are in progress to confi rm
transposition-mediated integration of individual transgenes by
sequence analysis of transposon-chromosome junctions recovered
by linear amplifi cation-mediated PCR Our data provide a platform
to establish a system for SB-mediated transposition of HSC and subsequent application to the treatment of human patients
692 Mechanical Loading of Stem Cells for Improvement of Cellular Cardiomyoplasty
Lauren Drowley,1 Theresa Cassino,1 Masaho Okada,1 Bradley Keller,2 Kimimasa Tobita,2 Philip LeDuc,3 Johnny Huard.1
1 University of Pittsburgh, Pittsburgh; 2 Children’s Hospital of Pittsburgh, Pittsburgh; 3 Carnegie Mellon University, Pittsburgh.
Although stem cell therapy for tissue repair is a rapidly developing
fi eld, the factors which dictate the physiological responsiveness of stem cells remain under investigation In this study we tested the hypothesis that controlling the loading history of muscle derived stem cells (MDSCs) with cyclic mechanical stimulation prior to transplantation signifi cantly improves MDSC survival and angiogenic effects on injured recipient myocardium Murine MDSCs were fi rst isolated using a preplating technique and then underwent 24 hours
of cyclic mechanical stretch To test their effi cacy for this loading history based approach, an acute myocardial infarction was created by permanently ligating the left coronary artery, and both unstimulated and mechanically stretched MDSCs were transplanted into the injured left ventricular myocardium Hearts implanted with mechanically preconditioned cells attenuated post-infarcted dilatation and sustained cardiac contractility for 12 weeks after myocardial infarction, which was signifi cantly better than hearts transplanted with non-stretched MDSCs Myocardium transplanted with stretched MDSCs also displayed signifi cantly higher angiogenesis in comparison to the non-stretched MDSC transplanted myocardium, which was further supported by a signifi cant increase in vascular endothelial growth factor secretion after mechanical preconditioning Results suggest that transplantation of mechanically stretched MDSCs into acute infarcted myocardium ameliorates post-infarcted remodeling better than non-stretched MDSC transplantation by promoting higher levels
of angiogenesis through paracrine factor secretion These fi ndings highlight the importance of loading history for increasing the effi cacy
of stem cell transplantation
693 Effect of IL-3 on Transduction Effi ciency
in CD34+ Cell-Derived-Erythroid Cultures with Lentiviral Vectors Expressing the Human beta-Flobin Gene
Leda Ferro,1 Clare Taylor,1 Daniel Hollyman,1 Michel Sadelain,1,2,3,4 Isabelle Riviere.1,2,3,4
1 Gene Transfer and Somatic Cell Engineering Facility, Memorial Sloan-Kettering Cancer Center, New York; 2 Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York;
3 Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York; 4 Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York.
Gene transfer approaches for β-thalassemia using recombinant LVs requires effi cient gene transfer into HSCs and high level, stable expression of the b-globin gene in the erythroid lineage Although LVs are able to transduce non-proliferating cells, HSCs display low permissiveness to LVs and require cytokine prestimulation and high vector doses for high transduction effi ciency Standard CD34+ prestimulation protocols use a combination of three early-acting cytokines, Stem Cell Factor (SCF), Thrombopoeitin (TPO) and Flt3 ligand (Flt3-L) IL-3 alone or in combination with other hematopoietic cytokines has been shown to support multilineage colony formation, improve lentiviral and retroviral transduction and expansion of different lineages in liquid culture However its effect
on the engraftment potential of cultured CD34+ cells is controversial
Trang 2Molecular Therapy Volume 17, Supplement 1, May 2009
STEM CELL THERAPIES II
We have developed a method to investigate the effects of different
prestimulation conditions on transduction effi ciency in vitro in short
term culture of GCS-F mobilized human peripheral blood (PB)
CD34+ cells Selected CD34+ cells are prestimulated, transduced
and differentiated into either myeloid (Dendritic cell) or erythroid
(Red blood cell) lineages in order to quantify vector copy number
(VCN) and transgene expression in the different lineages Using this
system we sought to investigate the effects of IL-3 prestimulation
using TNS9.3, a LV carrying the human β-globin gene and associated
regulatory sequences imparting erythroid-restricted transgene
expression, as well as the enhanced green fl uorescent protein (eGFP)
reporter gene driven by the human PGK promoter We demonstrate
that addition of IL-3 to the regular prestimulation cocktail (SCF, TPO
and Flt3-L) increases the percentage of eGFP positive cells from
10% to 35% and the average VCN from 0.5 to 1 After normalization
of the VCN to the percentage of GFP+ cells, the VCN per cell was
approximately 2.5 in the groups in which IL-3 was added and 5 with
the conventional cytokines prestimulation alone The VCN of single
erythroid and myeloid methylcellulose colonies was 1-3 (average 1.6)
for the groups in which the IL-3 was added and in the range of 1-5
(average 2.3) in the absence of IL-3 These data suggest that addition
of IL-3 increases the number of CD34+ progenitor cells permissive
to LV transduction Where as the absolute number of transduced cells
increases upon treatment with IL-3, we observed an accelerated loss
of the CD34 marker and an earlier onset of glycophorin A receptor
expression and a skewing of colony formation manifested as a
reduction in large immature colonies (BFU-E, CFU-GM) and an
increase of BFU-E, CFU-M and CFU-G We are currently performing
LTC-IC assays to further investigate the effect of IL-3 prestimulation
on self-renewal and multilineage potential of CD34+ cells
694 Optimization of Vector Design for Lentiviral
Gene Transfer into Human Embryonic Stem Cells
Emi Aizawa,1 Kaoru Mitsui,1 Keiichiro Suzuki,1 Hirofumi
Suemori,2 Norio Nakatsuji,3,4 Ko Mitani.1
1 Gene Therapy Division, Research Center for Genomic Medicine,
Saitama Medical University, Saitama, Japan; 2 Laboratory of
Embryonic Stem Cell Research, Stem Cell Research Center, Kyoto
University, Kyoto, Japan; 3 Department of Development and
Differentiation, Institute for Frontier Medical Sciences, Kyoto
University, Kyoto, Japan; 4 Institute for Integrated Cell-Material
Sciences, Kyoto University, Kyoto, Japan.
Lentiviral vectors (LVs) have become a valuable tool for gene
delivery because they can stably transduce a variety of cells, including
primate embryonic stem (ES) cells, in high effi ciency An important
characteristic of LVs is that they form a number of pseudotypes with
different tropisms by incorporating envelopes derived from other
viruses into the vector particles We compared ten pseudotypes
to optimize stable gene delivery into 293 cells, mouse ES (mES)
cells, cynomolgus monkey ES (cES) cells, and human ES (hES)
cells The envelope genes used for this experiment were those from
vesicular stomatitis virus (VSV-G), amphortopic retrovirus 4070A,
amphortopic retrovirus 10A1, gibbon ape leukemia virus (GALV),
RD114 feline endogenous virus, baculovirus (gp64), rabies virus,
Mokola virus, lymphocytic choriomeningitis virus (LCMV)-WE,
and LCMV-Arm536 Titers on each cell line were determined by
counting the number of G418-resistant colonies after infection with
a LV encoding the PGK-neo marker gene The VSV-G was the
most effective for stable gene transfer into 293 cells, mES cells, and
cES cells For hES cells, the gp64, the 4070A and the 10A1 have
been effective, as well as the VSV-G However, at multiplicities of
infection (MOIs) of higher than 100 vector particles/cell, the transfer
effi ciency with the gp64 was the highest Next, we have compared
the relative strengths as well as the extent of suppression of the
fi ve ubiquitous promoters as an internal promoter for LV in hES
cells They are the cytomegalovirus (CMV) enhancer/promoter, the human phosphoglycerate kinase (PGK) promoter, the mutant murine leukemia virus LTR (MNDU3c) enhancer/promoter, the human translation elongation factor 1 alpha (EF-1α) promoter, and the CMV enhancer/chicken β-actin (CAG) promoter They were tested
to drive the downstream enhanced green fl uorescent protein (EGFP) gene expression and the mean fl uorescence intensity was compared Because the titer of LV with CAG promoter was consistently lower than that with CMV by ∼10-fold, LV with an internal CAG was not investigated further While CMV was the strongest in 293 cells, EF-1α promoter showed the activity, which was higher than other three by approximately 3-fold, in hES cells Interestingly, for all four promoters, only 2-4% of the integrated vector expressed the marker gene, suggesting that high degree of suppression observed in human ES cells might be caused not by an internal promoter but by vector backbone sequences By using the EF-1α promoter in a gp64-pseudotyped LV, as high as 75% and 45% of the infected KhES-1cells and KhES-3 cells became GFP(+) at an MOI of 300, respectively Our results indicate that LVs are highly effi cient and versatile methods for gene transfer into hES cells and potentially other types of human stem cells, such as induced pluripotent stem cells
695 Application of a “Double-Feature”
Promoter To Identify Cardiomyocytes Differentiated from human Embryonic Stem Cells
Tamas I Orban,1 Agota Apati,1 Andrea Nemeth,1 Nora Varga,1 Virag Krizsik,1 Anita Schamberger,1 Gyorgy Varady,1 Katalin Nemet,1 Zsuzsanna Izsvak,2 Balazs Sarkadi.1
1 Membrane Research Group of the HAS, Semmelweis University and National Blood Center, Budapest, Hungary; 2 Mobile DNA Group, Max-Delbruck Center for Molecular Medicine, Berlin, Germany.
Human embryonic stem (HuES) cells represent a great potential for cell- and gene-therapy applications Apart from technical and experimental diffi culties, however, serious ethical concerns must
be resolved before they are actually used in clinical studies Major obstacles of HuES-based applications include the development of effi cient and stable gene delivery systems, as well as the effi cient control of directed tissue differentiations Nowadays, viral and non-viral applications are both used for gene transfer experiments and they are combined with various methods to obtain the tissue(s) of interest, including antibiotic selection with tissue-specific promoters or applying artifi cial drug cocktails Here we describe a novel approach
to identify tissues differentiated from HuES cells using a “double-feature” behavior of one version of the CAG promoter We generated GFP-expressing HuES clones under the expression of different promoters using the Sleeping Beauty non-viral transposon system
or the SEW lentiviral system Neither of the gene delivery methods modifi ed the subsequent differentiation of these HuES clones, and all kinds of tissue types could be identifi ed after a spontaneous differentiation via the embryoid body formation method By using the CAG promoter, in contrast to several other constitutive promoter
GFP expression was observed in differentiated cardiomyocytes This phenomenon was independent of the transgene sequence, methods
of gene delivery, copy number, and the integration sites Such
“double-feature” promoter behavior, that is providing a selectable marker for transgene expressing undifferentiated stem cells, and also specifi cally labeling differentiated cardiomyocytes, was assessed
by transcriptional profi ling To provide evidence that this promoter behavior manifests itself in tissue-dependent transcriptional profi les,
we collected and studied cell populations with different GFP signal intensities by fl uorescence activated cell sorting after differentiating
real-time quantitative PCR, we could confi rm that GFP mRNA levels